Kazuko Matsuda's Insider Trades & SAST Disclosures
Kazuko Matsuda's most recent trade in Medicinova Inc was a trade of 100,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kazuko Matsuda.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 157,500 | 157,500 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 149,625 | 149,625 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 192,500 | 192,500 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 60,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. | 23 Aug 2021 | 60,000 | 322,996 (0%) | 0% | 2.3 | 138,000 | Common Stock |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2021 | 56,250 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.46 per share. | 24 Jun 2021 | 56,250 | 262,996 (0%) | 0% | 2.5 | 138,375 | Common Stock |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 24 Jun 2021 | 46,554 | 206,746 (0%) | 0% | 2.5 | 118,247 | Common Stock |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2021 | 46,554 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 325,000 | 325,000 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.13 per share. | 12 Jun 2020 | 20,000 | 160,192 (0%) | 0% | 5.1 | 102,600 | Common Stock |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2020 | 20,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2020 | 28,446 | 46,554 | - | - | Employee Stock option (Right to Buy) | |
| Medicinova Inc | Kazuko Matsuda | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.54 per share. | 08 Apr 2020 | 28,446 | 140,192 (0%) | 0% | 2.5 | 72,253 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges